FTC accuses Reckitt Benckiser of blocking generic Suboxone
MLex Summary: The US Federal Trade Commission filed a complaint accusing Reckitt Benckiser Group of illegally maintaining a monopoly over the opioid addiction treatment Suboxone. According to the complaint, before the generic...To view the full article, register now.
Already a subscriber? Click here to view full article